JUSTIN HEWLETT: Open Payments
NPI 1467934737 · BLUFFDALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 98 payments from 23 companies in 2025. Trend: 2023 $674 · 2024 $2,216 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $235 |
| Novo Nordisk Inc | 14 | $211 |
| Amgen Inc. | 8 | $154 |
| SANOFI-AVENTIS U.S. LLC | 9 | $153 |
| Medtronic, Inc. | 7 | $141 |
| Neurocrine BioSciences, Inc. | 4 | $112 |
| Ascendis Pharma Endocrinology Inc | 4 | $104 |
| Ascensia Diabetes Care Us Inc. | 5 | $104 |
| Xeris Pharmaceuticals, Inc. | 5 | $98 |
| CeQur Corporation | 1 | $80 |
Products named: Kerendia, TZIELD, MINIMED 780G, EVENITY, Wegovy, Yorvipath, CRENESSITY, CeQur Simplicity.
Industry payments across UT — which companies pay providers there.
